The Various Segments that Comprise the...
To Know Where Biosimilars Are Going,...
It Remains Extremely Challenging to Identify...
RNAi Is Working on Tactics to...
Biotechnology equipment spells big bucks for the industry’s top CEOs. [© ALYUSHIN - Fotolia.com]
Olivier A. Filliol, President and CEO
2011 Compensation: $5,379,639
2010 Compensation: $5,393,903
% Change: -0.3%
Marc N. Casper, President and CEO
2011 Compensation: $5,516,567
2010 Compensation: $2,761,689
% Change: 99.8%
Jay T. Flatley, President, CEO and Director
2011 Compensation: $9,944,147
2010 Compensation: $6,608,974
% Change: 50.5%
Edward J. Ludwig, Chairman and CEO
2011 Compensation: $10,091,273
2010 Compensation: $10,005,022
% Change: 0.9%
William P. Sullivan, President and CEO
2011 Compensation: $10,252,264
2010 Compensation: $10,442,447
% Change: -1.8%
Gregory T. Lucier, Chairman and CEO
2011 Compensation: $10,897,630
2010 Compensation: $11,498,009
% Change: -5.2%
Robert F. Friel, Chairman and CEO
2011 Compensation: $12,819,181
2010 Compensation: $7,948,297
% Change: 61.3%
Leave a comment by clicking the “Comments” icon. We want to hear your thoughts!
Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?
Be sure to add [email protected]
to your Address Book or Safe Senders List.
here for instructions.
If you have any questions about your subscription, click
here to email us or call at (914) 740-2189.
You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
© 2016 Genetic Engineering & Biotechnology News All Rights Reserved